Proposed S.B. No. 923
Session Year 2025

AN ACT CONCERNING THE RESEARCH AND DEVELOPMENT TAX CREDIT EXCHANGE RATE FOR BIOTECHNOLOGY COMPANIES.

To increase the research and development tax credit exchange rate under section 12-217ee of the general statutes to one hundred per cent for biotechnology companies.

Other Bills with Similar Topics

  Biotechnology 

 

• HB07166 - AN ACT CONCERNING THE DEPARTMENT OF ECONOMIC AND COMMUNITY DEVELOPMENT'S RECOMMENDATIONS FOR REVISIONS TO CERTAIN COMMERCE AND TAX CREDIT STATUTES.
• HB07287 - AN ACT CONCERNING THE STATE BUDGET FOR THE BIENNIUM ENDING JUNE 30, 2027, AND MAKING APPROPRIATIONS THEREFOR, AND PROVISIONS RELATED TO REVENUE AND OTHER ITEMS IMPLEMENTING THE STATE BUDGET.
• SB00736 - AN ACT CONCERNING RESEARCH AND DEVELOPMENT TAX CREDITS FOR BIOTECHNOLOGY COMPANIES.

  Corporation business tax credits for research and development expenses 

 

• HB06739 - AN ACT ESTABLISHING A BUY CONNECTICUT PROGRAM FOR DEFENSE CONTRACTORS.
• HB07008 - AN ACT CONCERNING A RESEARCH AND DEVELOPMENT EXPENSES TAX CREDIT FOR PASS-THROUGH ENTITIES.
• HB07287 - AN ACT CONCERNING THE STATE BUDGET FOR THE BIENNIUM ENDING JUNE 30, 2027, AND MAKING APPROPRIATIONS THEREFOR, AND PROVISIONS RELATED TO REVENUE AND OTHER ITEMS IMPLEMENTING THE STATE BUDGET.